Clinical Study of Tanshinone Capsules Against COVID-19
- Conditions
- COVID-19 (Coronavirus Disease 2019)
- Interventions
- Drug: Tanshinone capsules
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Liu Shuwen
- Target Recruit Count
- 80
- Registration Number
- NCT07123701
- Locations
- 🇨🇳
Dongguan People's Hospital, Dongguan, Guangdong, China
Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors
- Conditions
- MelanomaPancreatic CancerMAP Kinase Family Gene MutationRAS MutationSolid TumorRAF MutationPilocytic AstrocytomaColorectal CancerNon Small Cell Lung CancerMEK Mutation
- Interventions
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Day One Biopharmaceuticals, Inc.
- Target Recruit Count
- 44
- Registration Number
- NCT07121829
- Locations
- 🇺🇸
The Angeles Clinic, Los Angeles, California, United States
🇺🇸Hoag Health, Newport Beach, California, United States
🇺🇸University of Colorado Hospital, Aurora, Colorado, United States
Mediterranean Diet Education in Shift Nurses: Effects on Sleep, Activity, and Health Parameters
- Conditions
- Obesity PreventionHypertensionType 2 Diabetes Mellitus (T2DM)Occupational HealthCardiovascular DiseasesMetabolic SyndromeAtheroscleroses
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Bahçeşehir University
- Target Recruit Count
- 130
- Registration Number
- NCT07123610
- Locations
- 🇹🇷
Bodrum Acıbadem Hospital, Muğla, Bodrum, Turkey
Hyperventilation and Physical Performance in Obesity
- Conditions
- Obesity
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Istinye University
- Target Recruit Count
- 30
- Registration Number
- NCT07122804
- Locations
- 🇹🇷
Istinye University, Istanbul, Turkey
Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism
- Conditions
- Secondary Hyperparathyroidism, Chronic Kidney Disease
- Interventions
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Shaanxi Micot Pharmaceutical Technology Co., Ltd.
- Target Recruit Count
- 424
- Registration Number
- NCT07122401
- Locations
- 🇨🇳
Zhongshan Hospital, Shanghai, Shanghai, China
A Targeted Electronic Health Approach to Reduce Fear of Recurrence in Breast Cancer Survivors (FoRtitude)
- Conditions
- Breast Cancer SurvivorFear of Cancer Recurrence
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 800
- Registration Number
- NCT07122492
- Locations
- 🇺🇸
UNC Chapel Hill School of Medicine Public Health, Chapel Hill, North Carolina, United States
Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder
- Conditions
- Generalized Anxiety Disorder (GAD)Anxiety Disorders
- Interventions
- Drug: Moderate-Dose CannabidiolDrug: Low-Dose CannabidiolDrug: Placebo Matched to Moderate-Dose CannabidiolDrug: Placebo Matched to Low-Dose Cannabidiol
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Wayne State University
- Target Recruit Count
- 90
- Registration Number
- NCT07123467
- Locations
- 🇺🇸
Wayne State University Eugene Applebaum College of Pharmacy & Health Sciences, Detroit, Michigan, United States
🇺🇸Wayne State University School of Medicine, Tolan Park Medical Building, Detroit, Michigan, United States
The Influence of Specialized Food Products Based on Ice-Cream on Esophageal Motility
- Conditions
- Ineffective Esophageal MotilityGERD (Gastroesophageal Reflux Disease)
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
- Target Recruit Count
- 30
- Registration Number
- NCT07121803
- Locations
- 🇷🇺
Dpt Gastroenterology, Hepatology and Nutrition, Federal Research Centre of Nutrition and Biotechnology, Kashirskoye shosse, bld 21, Moscow, Russia., Moscow, Russian Federation
Ex-vivo Confocal Imaging and Proteomic Profiling to Determine Treatment Response in Children With IBD
- Conditions
- IBD (Inflammatory Bowel Disease)IBDIBD - Inflammatory Bowel Disease
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Cook Children's Health Care System
- Target Recruit Count
- 40
- Registration Number
- NCT07121920
- Locations
- 🇺🇸
University of Texas at Arlington, Arlington, Texas, United States
🇺🇸Cook Children's Health Care System, Fort Worth, Texas, United States
Arrhythmia Cohort Study
- Conditions
- Arrhythmia
- Interventions
- Device: Normal treatment with catheter ablation or medicineDrug: Drug Treatment
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Beijing Anzhen Hospital
- Target Recruit Count
- 10000
- Registration Number
- NCT07123896
- Locations
- 🇨🇳
Deyong Long, Beijing, China